Taiwan Semiconductor Manufacturing Company's planned Arizona gigafab cluster, backed by a US$250 billion U.S.-Taiwan initiative, underscores its pivotal role in powering the AI revolution while raising questions about capital intensity and long-term returns in the reshoring era.
Elon Musk is exploring strategic mergers for SpaceX, with discussions underway for potential combinations with either Tesla or his AI startup xAI, as the billionaire seeks to consolidate his sprawling technological ventures ahead of a landmark public offering.
South African low-cost carrier Lift has secured membership in the International Air Transport Association (IATA), a key milestone that validates its business model and facilitates its planned regional expansion into Mauritius and Reunion.
President Donald Trump has nominated Kevin Warsh, a former Federal Reserve governor known for his hawkish views and nuanced stance on Bitcoin, to chair the central bank. The move sets the stage for a contentious Senate confirmation battle and could herald a significant shift in U.S. monetary policy.
Under new leadership, Verizon posts its best subscriber growth in years, outlines a massive cost-cutting plan, and signals a strategic pivot towards customer retention and convergence, backed by the completed Frontier acquisition.
Tesla's latest earnings call, emphasizing a strategic shift towards autonomous vehicles and robotics, has drawn a spectrum of reactions from prominent investors. While some see it as a necessary evolution, others warn of significant costs and transitional risks, creating a clear divide in analyst sentiment.
As gold and the popular GLD ETF hit historic highs, retail and institutional investors alike are grappling with a critical question: is this a sustainable shift or a speculative peak? We examine the drivers behind the surge and the debate on what comes next.
While U.S.-Asia trade tensions dampened trans-Pacific volumes, robust growth in intra-Asia and Europe-Asia corridors propelled the air freight industry to a year of expansion and adaptation, signaling a shift in global trade patterns.
In a landmark shift, Venezuela's parliament has passed sweeping reforms to its hydrocarbons law, aiming to lure private capital into its crippled oil industry. The move, backed by a new U.S. license, signals a potential turning point for the nation's economy.
Initial unemployment filings in Virginia rose by over 27% last week, contrasting with a slight national decline and highlighting regional economic disparities.
Despite a challenging mortgage landscape and specific credit headwinds, Hilltop Holdings Inc. (HTH) reported a 46% surge in annual net income for 2025, buoyed by a steepening yield curve and disciplined cost management across its banking, lending, and securities divisions.
Shares in Canadian aerospace giant Bombardier plunged 9% following former U.S. President Donald Trump's threat to impose 50% tariffs and decertify its aircraft, escalating trade tensions and sparking alarm across the North American aviation industry.
Saks Global moves to close over 60 Off 5th locations as part of Chapter 11 proceedings, signaling a strategic retreat from the competitive off-price segment to focus on core luxury brands.
With the specter of U.S. military action looming, Iran is engaging in a frantic diplomatic push with regional powers like Turkey, while global capitals scramble to prevent a full-scale war. Despite the outreach, analysts warn the window for de-escalation is narrowing.
Goldman Sachs raises its price target for Zeta Global (ZETA), citing strategic positioning ahead of an expected surge in software sector mergers and acquisitions driven by valuation gaps and synergy potential.
Rosenblatt Securities initiates coverage on Credo Technology with a Neutral rating and a $170 price target, highlighting its strong position in high-speed connectivity for AI infrastructure while flagging competitive pressures. The note follows a more bullish target hike from Barclays earlier in the month.
Erasca Inc. (ERAS) sees its price target raised from $5 to $12 by Guggenheim, following promising clinical data for its lead oncology candidates and updated financial models. The move comes amid a series of positive analyst revisions for the clinical-stage biopharma firm.
Clinical-stage biopharma Alumis Inc. (ALMS) is gaining significant Wall Street attention after its lead drug candidate, envudeucitinib, successfully met all endpoints in key Phase 3 trials for plaque psoriasis, prompting multiple analyst upgrades and optimistic price targets.
Analyst firm Piper Sandler reiterates its Overweight rating on AGNC Investment Corp., highlighting a favorable shift in agency mortgage-backed securities spreads that could bolster the REIT's book value.
UBS initiates coverage on Rithm Capital with a Buy rating and a $16 price target, highlighting the REIT's aggressive acquisition strategy—including the purchases of Paramount Group and Crestline—as a key driver for expanding its asset management footprint and unlocking shareholder value.
